GHK-Cu is a copper complex of glycyl-histidyl-lysine studied for its effects on extracellular-matrix production and remodeling in experimental tissue-repair systems.
Explore the research profileSubmit an unpaid laboratory order request for manual review. Availability and any pending amounts require confirmation.
Catalog quantities are not assay results.
Copper-binding tripeptide complex
GHK consists of glycine, histidine and lysine, a three-amino-acid sequence originally identified in human plasma. GHK-Cu refers to its complex with copper(II). The free peptide, the copper complex and unbound copper are related experimental materials with potentially different biological effects.
This reference describes the published literature. Exact supplied form and chemical specifications require product-specific documentation. The studies are linked in Selected literature.
Foundational studies reported changes in fibroblast collagen synthesis and in enzymes that remodel the surrounding extracellular matrix. This encompasses both matrix production and matrix turnover. A later experiment found that copper alone reproduced some MMP-2 effects, whereas the uncomplexed peptide did not, emphasizing the importance of appropriate controls.
An early fibroblast-culture study reported increased collagen synthesis following exposure to GHK-Cu. Cultured fibroblasts provide a controlled way to measure matrix production, although a biochemical response in isolated cells does not establish a clinical wound-healing benefit. [1]
Investigators examined MMP-2, an enzyme involved in extracellular-matrix turnover, together with its tissue inhibitors. Changes in both enzymes and inhibitors point to a remodeling response whose consequences depend on the surrounding tissue and experimental conditions. [2]
Rat wound chambers exposed to GHK-Cu accumulated more collagen and other matrix-associated components than controls. This specialized animal model measures tissue accumulation; it cannot by itself answer questions about human scars, skin appearance or recovery from injury. [3]
Study topics describe the cited models, not established benefits of this catalog material.
The cited primary studies establish a laboratory rationale for studying copper-peptide interactions in connective tissue. They are preclinical studies, not controlled human efficacy trials, and the research outcomes are specific to the models and measurements described.
More collagen is not automatically better repair, and matrix quantity does not fully describe tissue architecture or function. Copper concentration, complex formation and exposure conditions can affect interpretation. These papers provide no verification of WYZ purity, copper content, manufacturing consistency or suitability for human application.
Primary studies and clearly identified supporting sources. Each link opens the original record.
Foundational fibroblast collagen-synthesis experiment.
MMP-2 and TIMP responses; includes copper and free-peptide comparisons.
Rat wound-chamber matrix accumulation; not a human clinical trial.
Literature reviewed October 2026. This is a selected research overview, not an exhaustive systematic review. Published findings do not establish the identity, purity, sterility or suitability of any WYZ batch. For laboratory research only; not for human or veterinary use.
Final product specifications and product-specific storage instructions have not been supplied. Review the original documentation and your laboratory’s procedures before obtaining or using the material.
For qualified laboratory researchers. Not for human or veterinary use. Product information is not medical advice or a recommendation for personal use.
What to look for in a COAOther single compounds in the collection.
Metabolic Research
Retatrutide is a synthetic peptide studied for coordinated activation of three metabolic hormone receptors, with human research examining glucose regulation, appetite, body weight and liver fat.
Metabolic Research
MOTS-c is a mitochondrial-derived peptide studied in metabolic signaling and skeletal-muscle adaptation, with experimental interventions supported mainly by cell and animal evidence.
Secretagogue Research
Tesamorelin is a stabilized GHRH analogue studied for changes in visceral and liver fat, principally in people with HIV-associated abdominal adiposity.
